GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Clinical trials for GERD (GASTROESOPHAGEAL REFLUX DISEASE) explained in plain language.
Never miss a new study
Get alerted when new GERD (GASTROESOPHAGEAL REFLUX DISEASE) trials appear
Sign up with your email to follow new studies for GERD (GASTROESOPHAGEAL REFLUX DISEASE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New POEM technique aims to cut reflux risk in achalasia patients
Disease control Not yet recruitingThis study compares two versions of a minimally invasive surgery (POEM) for achalasia, a condition that makes swallowing difficult. The standard surgery often leads to severe acid reflux. The modified version tries to preserve certain muscle fibers to reduce that risk. About 120 …
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: NA • Sponsor: University of California, Irvine • Aim: Disease control
Last updated May 17, 2026 09:10 UTC
-
New GERD drug aims to keep esophagus healed longer
Disease control Not yet recruitingThis phase 3 trial tests whether a new drug, linaprazan glurate, can keep the esophagus healed in people with healed erosive esophagitis from GERD, compared to the standard drug lansoprazole. About 1050 adults who were healed in a prior trial will take either high or low dose lin…
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated May 17, 2026 09:05 UTC
-
New GERD drug aims to heal esophagus faster than current treatment
Disease control Not yet recruitingThis study tests a new medicine called linaprazan glurate to see if it heals esophagus damage from GERD better than the standard drug lansoprazole. About 500 adults with erosive esophagitis will take either the new drug or the standard one for up to 8 weeks. Doctors will use came…
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated May 15, 2026 11:56 UTC